research Patient History Sheds Light on Telogen Effluvium
Hair loss called telogen effluvium can be better understood by looking at a patient's medical history.
Search
for
Sort by
Research
840-870 / 1000+ results 
research Alopecia in preexisting autoimmune thyroid disease in family medicine practice: can hyperprolactinemia induce hair loss? A case report
High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.
research Simplified Lateral Brow Lift under Local Anesthesia for Correction of Lateral Hooding
The procedure safely and effectively lifted the lateral brow, improving appearance with minimal complications.
research A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19
More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.
research Getting under the skin of hair aging: the impact of the hair follicle environment
Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.
research 190 Deficiency of the Human Cysteine Protease Inhibitor Cystatin M/E Causes Hypotrichosis and Dry Skin
Not having enough cystatin M/E protein causes less hair growth and dry skin.
research Alopecia areata incognita
Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.
research Managing hair loss
Different causes of hair loss require specific treatments, and most men and women will experience some form of hair thinning as they age.
research Evaluation of the Demographic Characteristics and the Factors Related to Eyebrow Involvement in Frontal Fibrosing Alopecia: A Retrospective, Cross-sectional, Single Center Study
Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.
research Effects of latanoprost on vascular endothelial growth factor protein synthesis in human dermal papilla cells
Latanoprost increases VEGF protein in human cells, which may help hair growth.
research Perilymphatic Atrophy of the Skin
Corticosteroid injections for hair loss can cause skin thinning.
research Alteration in Asbabe-Sitta-Zaruriyah (Six essential pre-requisite for maintaining health) to prevent Intithār al-Sha‘r (Telogen Effluvium): An Insight
Changing six essential health practices can help prevent excessive hair shedding.
research What Ages Hair?
Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.
research Generalized Hypertrichosis Due to Topical Minoxidil
A woman experienced excessive hair growth after using a hair loss treatment with minoxidil.
research Telogen Effluvium
Telogen effluvium is a condition that causes temporary hair loss.
research Brow Lift
Brow lifts raise and smooth the forehead and can lower the hairline.
research Eyebrow transplant
Eyebrow transplants use hair from the scalp or pubic area, with blonde hair looking more natural, and can leave scars depending on the method used.
research Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of FP-receptor activation
Topical latanoprost acid at 0.05% concentration improved hair growth in women with androgenetic alopecia.
research Hair and Aging.
Hair becomes thinner, grayer, and may fall out more as people get older, and styling habits can worsen these effects.
research Human Hair Growth Deficiency Is Linked to a Genetic Defect in the Phospholipase Gene LIPH
A genetic mutation in the LIPH gene causes hair loss and growth defects.
research Trichoscopic criteria of female pattern hair loss
Female hair loss can be diagnosed using specific trichoscopy criteria.
research Culprits of Medication-Induced Telogen Effluvium, Part 2
Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.
research Scalp Disorder: Telogen Effulvium
Telogen effluvium is a common hair loss where hair sheds due to stress but new hair still grows.
research Alopecia in a 19-Month-Old Boy
A 19-month-old boy with a rare hair disorder showed mild improvement with treatment, but his family chose gentle hair care due to limited success.
research Tratamiento de alopecia androgenética con Sabal serrulata y péptidos biomiméticos vehiculizados con microneedling
The treatment improved hair growth and thickness in most patients with minimal side effects.
research Diffuse hair loss
Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.
research Characterization and management of hypertrichosis induced by low-dose oral minoxidil in the treatment of hair loss
Low-dose oral minoxidil for hair loss can cause mild excessive hair growth, usually appearing within the first 3 months, but it can be managed by adjusting the dose or removing the unwanted hair, with most people not needing to stop the treatment.
research Two females with hair loss
A mother and daughter have a rare genetic hair loss disorder with no effective treatment.
research LB1158 A novel more effective topical therapeutic approach for treatment of androgenetic alopecia: First in human trial results for topical ET-02
5% ET-02 is a more effective and safe treatment for hair loss than current options.
research Drugs targeting epithelial–mesenchymal transition molecules for treatment of lichen planopilaris
Drugs targeting EMT molecules show promise for treating lichen planopilaris.